INTRAVENOUS FERRIC CARBOXYMALTOSE VS ORAL IRON IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY: RESULTS OF THE RANDOMISED FIND-CKD STUDY

被引：0
|
作者：
Macdougall, I. D. [1 ]
Bock, A. [2 ]
Carrera, F. [3 ]
Eckardt, K-U [4 ]
Gaillard, C. [5 ]
Van Wyck, D. [6 ]
Roubert, B. [7 ]
Nolen, J. [7 ]
Roger, S. D. [8 ]
机构：
[1] Kings Coll Hosp London, London, England
[2] Kantonsspital, Aarau, Switzerland
[3] Eurodial, Leiria, Portugal
[4] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany
[5] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
[6] Davita Healthcare Partners Inc, Denver, CO USA
[7] Vifor Pharma, Glattbrugg, Switzerland
[8] Renal Res, Gosford, Australia
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SO049
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [41] Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial
    Nagaraju, Shankar P.
    Cohn, Adam
    Akbari, Ayub
    Davis, Janet L.
    Zimmerman, Deborah L.
    [J]. BMC NEPHROLOGY, 2013, 14
  • [42] Retrospective Assessment of Total Cost of Care in Non-Dialysis Dependent Chronic Kidney Disease Patients Receiving Parenteral Iron Therapy for Iron Deficiency Anemia
    Wang, Kevin
    Kwong, Jackie
    Wang, Peng
    Boccia, Ralph, V
    [J]. BLOOD, 2022, 140 : 4998 - 4999
  • [43] FERRIC CITRATE INCREASES HEMOGLOBIN IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY ANEMIA.
    Pergola, P. E.
    Fishbane, S.
    Neylan, J. F.
    Uhlig, K.
    Chertow, G. M.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (04) : A76 - A76
  • [44] IV iron treatment of iron deficiency anaemia with ferumoxytol in patients with inflammatory bowel disease unable to take oral iron: A randomised controlled trial vs. ferric carboxymaltose
    Strauss, W.
    Dahl, N.
    Jiang, J.
    Bernard, K.
    Kaper, R.
    Krop, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S416 - S417
  • [45] Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease
    Agarwal, R.
    Rizkala, A. R.
    Kaskas, M. O.
    Minasian, R.
    Trout, J. R.
    [J]. KIDNEY INTERNATIONAL, 2007, 72 (05) : 638 - 642
  • [46] Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease
    Jaber, B. L.
    [J]. KIDNEY INTERNATIONAL, 2008, 73 (04) : 511 - 512
  • [47] Editorial: Management of Patients With Non-dialysis Dependent Chronic Kidney Disease (ND-CKD)
    Provenzano, Michele
    Garofalo, Carlo
    Gorriz, Jose Luis
    Andreucci, Michele
    [J]. FRONTIERS IN MEDICINE, 2022, 8
  • [48] THE TREATMENT OF IRON DEFICIENCY/ANAEMIA IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE IN GERMANY - A CLAIMS DATABASE ANALYSIS
    Haas, J. S.
    Borchert, K.
    Krinke, K.
    Gavata-Steiger, S.
    Greiner, W.
    Braun, S.
    [J]. VALUE IN HEALTH, 2018, 21 : S476 - S477
  • [49] IMPACT OF ANEMIA AND IRON PARAMETERS ON HYPOTHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS
    Mehedinti, Ana Maria
    Capusa, Cristina
    Corbu, Alexandra
    Chiriac, Corina
    Andreiana, Iuliana
    Mircescu, Gabriel
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [50] Safety and tolerability of ferric carboxymaltose (FCM) for treatment of iron deficiency in patients with chronic kidney disease and in kidney transplant recipients
    Grimmelt, A. -C.
    Cohen, C. D.
    Fehr, T.
    Serra, A.
    Wuethrich, R. P.
    [J]. SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 13S - 13S
12345